Establishing secure connection…Loading editor…Preparing document…

Biosciences Document Template

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BIOSCIENCES SERVICES AGREEMENT

This Biosciences Services Agreement ("Agreement") is made and entered into as of by and between Client Name: and Service Provider Name: .

Parties and Contact Information

WHEREAS

WHEREAS, Client requires specialized biosciences services, which may include laboratory testing, sample processing, protocol development, and analytical reporting (collectively, "Services");

WHEREAS, Provider represents that it has the technical qualifications, facilities, personnel, equipment, and regulatory controls necessary to perform the Services in accordance with applicable professional standards and the terms of this Agreement;

WHEREAS, the parties desire to set forth the terms and conditions under which Provider will provide the Services and Client will compensate Provider.

Scope of Work

Provider will perform the Services as described below. Any material changes to the scope, deliverables, estimated timelines, or required biosafety level must be agreed in writing by both parties prior to implementation.

Payment Terms

Total Fee: $ . Payment shall be made in accordance with the schedule set forth below.

Invoices are due within days of receipt. Late payments shall accrue interest at the lesser of 1.5% per month or the maximum rate permitted by law. Late fee/interest rate:

Term and Termination

The term of this Agreement shall commence on and shall continue until unless earlier terminated in accordance with this Section.

Either party may terminate this Agreement for convenience upon days' prior written notice to the other party. Either party may terminate immediately for material breach by the other party if such breach remains uncured for thirty (30) days after written notice describing the breach, or immediately if the breach cannot reasonably be cured within that period and the breaching party fails to commence cure within that period and diligently pursue cure to completion.

Confidentiality

"Confidential Information" means non-public information disclosed by one party to the other in any form that is designated as confidential or that by its nature should reasonably be understood to be confidential, including but not limited to data, protocols, assays, experimental results, biological materials, and proprietary methods. Each party shall: (a) use Confidential Information only for the purposes of performing this Agreement; (b) restrict disclosure to employees, agents, consultants, or contractors who have a need to know and who are bound to confidentiality obligations at least as protective as this Agreement; and (c) protect Confidential Information with at least the same degree of care it uses to protect its own confidential information, but in no event less than reasonable care.

Confidential Information shall not include information that is or becomes publicly available through no breach of this Agreement, is rightfully received from a third party without restriction, is independently developed without use of the disclosing party's Confidential Information, or is required to be disclosed by law or judicial process (provided prompt notice is given and disclosure is limited to the required minimum).

The obligations under this Confidentiality section shall continue for years from the date of disclosure, except that trade secrets shall be protected for so long as they qualify as trade secret under applicable law.

Materials, Data and Regulatory Compliance

If Client provides biological materials, Client shall warrant it has the right to provide such materials and that they are accompanied by complete and accurate information regarding hazards, biosafety level, and storage/transport requirements. Provider shall handle all materials in accordance with applicable biosafety practices and documented protocols. Provider shall not use or transfer Client materials for any purpose other than performance of the Services without Client's prior written consent.

Intellectual Property and Reports

Subject to Client's ownership of any Client-supplied materials, Provider shall retain ownership of its background intellectual property. Client shall own intellectual property in original data and reports generated specifically under this Agreement, provided Client is not in material breach of payment obligations. Provider grants Client a non-exclusive, royalty-free license to Provider background technology only to the extent reasonably necessary to use the deliverables. Any joint inventions shall be addressed by a separate written agreement.

Indemnification and Limitation of Liability

Each party shall indemnify and hold harmless the other party from third-party claims arising from its gross negligence or willful misconduct in connection with this Agreement, subject to applicable law. Except for liability arising from willful misconduct, gross negligence, or breaches of confidentiality, neither party shall be liable for consequential, incidental, or punitive damages. The aggregate liability of either party for any claim arising under this Agreement shall not exceed the total fees paid to Provider under this Agreement in the twelve (12) months preceding the claim.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflicts of law rules.

Entire Agreement; Amendments

This Agreement, including any exhibits and written statements of work referenced herein, constitutes the entire agreement between the parties and supersedes all prior discussions, proposals, and agreements relating to the Services. Any amendment or waiver must be in writing and signed by authorized representatives of both parties.

Miscellaneous

Neither party may assign this Agreement without the prior written consent of the other, except that either party may assign to an affiliate or in connection with a merger or sale of substantially all assets provided the assignee assumes the obligations hereunder. Notices shall be in writing and delivered to the addresses set forth above or to such other address as a party may designate in writing.

Client Printed Name:

By:

Date:

Provider Printed Name:

By:

Date:

Enter text✕

What the Biosciences Document Template Is

The Biosciences Document Template is a structured, reusable form designed to capture required information for bioscience workflows such as sample submissions, study protocols, material transfer, and data-sharing agreements. It standardizes fields for parties, specimen identifiers, study or protocol numbers, consent and authorization status, storage instructions, and chain-of-custody entries to reduce manual errors and support regulatory traceability. The template can be adapted for clinical research, laboratory services, or commercial testing where accurate metadata and signer attribution are essential for compliance and reproducibility.

Why a Standard Template Matters for Biosciences Workflows

A consistent template reduces errors, speeds onboarding, and preserves a clear audit trail for samples and data. For regulated contexts it supports compliance with ESIGN (15 U.S.C. §7001), UETA where adopted, and industry rules such as HIPAA and FDA recordkeeping, making electronic execution and records defensible in audits and inspections.

Why a Standard Template Matters for Biosciences Workflows

Who Typically Completes This Template

Use the template to centralize data collection and simplify signature capture, while retaining version history for regulatory review.

  • Principal investigators and lab directors who must document protocol, approvals, and responsibilities for specimens and data.
  • Research coordinators and sample managers who track sample custody, chain-of-custody timestamps, and storage locations.
  • Regulatory or quality managers who need standardized records for audits, IRB submissions, and compliance reviews.

Who Signs and Approves

Principal Investigator

Typically the senior researcher or PI endorses protocol-level documents and assumes responsibility for compliance. Their signature confirms protocol adherence, oversight of sample handling, and acceptance of study obligations; organizations often require the PI to be identifiable by full legal name and institutional affiliation.

Lab Manager

Lab managers or authorized designees execute sample receipt or processing sections and maintain chain-of-custody logs. Their signature verifies physical custody, storage conditions, and that samples were processed according to documented procedures and institutional policies.

Essential Sections to Include in a Professional Template

Design the template to capture administrative, scientific, and compliance details so each completed form serves both operational and regulatory needs.

Header Metadata

Include document title, version number, template ID, and effective date so reviewers can identify the correct form and track revisions across projects and audits.

Parties and Affiliations

Record full legal names, institutional affiliations, departmental contacts, and billing information for every submitting and receiving party to establish accountability and support invoicing or agreements.

Protocol and Project IDs

Capture IRB protocol number, study ID, or project code to tie the submission to approval records and permit cross-referencing during monitoring or inspection.

Sample Details

Provide structured fields for sample ID, collection date/time, specimen type, preservatives, volume, and storage temperature to prevent mislabeling and maintain chain-of-custody.

Consent & Authorizations

Document patient or donor consent status, consent document reference, and any data-use restrictions; this supports HIPAA-compliant handling and secondary-use determinations.

Signatures & Audit Trail

Include signer names, roles, dates, and a tamper-evident audit trail capturing timestamps, IPs, and authentication method to preserve legal validity and investigational records.

Required Information and Key Fields

Sample ID: Unique alphanumeric code
Protocol Number: IRB or study ID
Collector Name: Full legal name
Collection Date: MM/DD/YYYY format
Consent Status: Signed / Not signed
Storage Location: Freezer/room + unit

Step-by-Step: Complete the Biosciences Template

Follow a standard sequence to reduce rework: confirm project IDs, enter sample metadata, attach consents, require required approvals, and capture signatures with audit data.

  • 01
    Prepare: Confirm protocol, attach consent documents
  • 02
    Enter metadata: Complete sample and collection fields
  • 03
    Authorize: Collect approvals and reviewer initials
  • 04
    Sign: Capture signatures and save audit trail

How to Configure the Template for Online Use

Set up conditional logic and signer order to match your operational approval flow before sending the template for signatures.

Field Configuration
Form Template Select base template and versioning
Conditional Fields Show fields when criteria apply
Signer Order Define sequential or parallel signing
Authentication Choose email, SMS, or KBA

Where Completed Templates Are Sent

Decide routing destinations and retention policies in advance so completed documents flow to the right systems and custodians automatically.

  • Local Archive: Store a signed PDF in a secure file share
  • LIMS Integration: Push sample metadata to LIMS or ELN
  • Regulatory Folder: Copy final records to compliance repository
  • Requester Copy: Email signed copy to submitting party

Digital Signing and Platform Compatibility

Ensure your electronic signing platform supports required file types, authentication levels, and audit logs before e-submission.

  • File Formats: PDF, DOCX, and structured XML supported
  • Integrations: Salesforce, NetSuite, Microsoft 365 available
  • Authentication: Email, SMS, KBA, and SSO options

Key Timing Considerations and Deadlines

Track approval and submission windows so samples and associated records meet protocol and regulatory timing requirements.

IRB Approval Needed:

Before any human-subject sample processing begins

Sample Stability Window:

Submit within specified hours post-collection for valid testing

Data Reporting:

Send results within project-defined reporting intervals

Retention Start:

Retention begins on document creation or last effective date

HIPAA Recordkeeping:

Maintain PHI records per applicable timelines

Typical Processing Milestones

A staged timeline helps coordinate review, approval, processing, and archival activities for each submitted template.

01

Drafting

Create and review the template content and metadata fields before release

02

Internal Review

Quality and compliance teams verify required fields and approvals

03

Execution

Collect required signatures and audit logs for the finalized record

04

Archival

Store the signed record in the long-term compliance repository

Common Mistakes to Avoid

  • Leaving protocol or IRB number blank, which severs linkage to approval records and delays processing.
  • Using nonstandard sample IDs or reusing identifiers, causing sample misidentification and invalid results.
  • Failing to capture consent language or signature provenance, risking HIPAA noncompliance and audit findings.
  • Incorrect signer order or missing signatures leading to incomplete approvals and rejected submissions.

Risks and Consequences of Incorrect or Incomplete Records

Invalid Consent: Loss of authorization
HIPAA Violation: Civil penalties possible
Data Integrity Issue: Research results unreliable
Regulatory Fines: Agency enforcement risk
Sample Loss: Irreversible testing impact
Funding Delays: Contractual milestones missed

Real-World Examples of Template Use

Organizations across research and clinical services use standardized templates to accelerate workflows, preserve compliance, and improve handoffs.

Optica Ventures

Optica standardized submission forms to centralize approvals and reduce processing time by eliminating manual steps.

  • Solution streamlined sign-offs across distributed teams.
  • The change improved turnaround for sample intake, reduced errors, and made audit trails consistently available across projects, supporting faster study starts and clearer sponsor reporting.

Fertility Centers of Illinois

The fertility center implemented digital forms for patient consents and specimen tracking to maintain compliance.

  • Electronic audit trails preserved signer attribution.
  • This enabled the organization to manage remote consenting while retaining HIPAA-focused controls, improving record completeness and operational flexibility for mobile and in-person workflows.

eSignature Pricing and Feature Comparison

Compare typical starting prices and feature availability for common eSignature vendors to align cost and compliance needs without assuming one-size-fits-all.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial Yes, 7-day trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently Asked Questions and Troubleshooting

Answers to common questions about completing, signing, and submitting the Biosciences Document Template, and resolving common errors.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users